Dentsply SironaXRAY +5.75%51 3-Year ROIIC % is 3.73 as of Dec. 2025, which is 19% above its 10-year median of 3.13. GuruFocus rates XRAY with a GF Score™ of 51/100 and a GF Value™ of $19.03 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 54.07% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Dentsply Sirona's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 3.73%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Dentsply Sirona's 3-Year ROIIC % or its related term are showing as below:
XRAY's 3-Year ROIIC % is ranked better than 54.07% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.67
vs XRAY: 3.73
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Dentsply Sirona 3-Year ROIIC % Related Terms
Dentsply Sirona 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRAY vs LMAT, PLSE, KMTS: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's 3-Year ROIIC % falls into.
Dentsply Sirona's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 252 (Dec. 2025) - 327.782 (Dec. 2022) )
/
( 4513 (Dec. 2025) - 6546 (Dec. 2022) )
=
-75.782
/
-2033
=
3.73%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Dentsply Sirona (XRAY) has a 3-Year ROIIC % of 3.73 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dentsply Sirona and its competitors. This is 19% above median its historical median of 3.13. Over the past decade, Dentsply Sirona's 3-Year ROIIC % has ranged from 0.11 to 27.02. According to the industry distribution chart, Dentsply Sirona ranks #367 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 45.9%.
Is Dentsply Sirona's 3-Year ROIIC % too high?
Dentsply Sirona's current 3-Year ROIIC % of 3.73 is 19% above median its 10-year median of 3.13. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 27.02. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.67. Dentsply Sirona's value of 3.73 is 123.4% above this industry median. Based on the distribution chart, Dentsply Sirona ranks #367 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's 3-Year ROIIC % compare to LMAT and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #367 out of 799 companies for 3-Year ROIIC %. This puts Dentsply Sirona in the upper half of its industry. The industry median 3-Year ROIIC % is 1.67. Dentsply Sirona's value of 3.73 is 123.4% above this benchmark. Historically, Dentsply Sirona's own 3-Year ROIIC % has ranged from 0.11 to 27.02 over the past decade. While the company's 10-year median is 3.13 vs. the industry median of 1.67, Dentsply Sirona has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.67, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dentsply Sirona's current 3-Year ROIIC % of 3.73 is 123.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Dentsply Sirona and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current 3-Year ROIIC % is 3.73, which is 19% above median its own 10-year median of 3.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.03, compared to a current price of $12.32 — trading 35.3% below its estimated fair value. The current 3-Year ROIIC % is 3.73, which is 19% above median its 10-year median of 3.13 and 123.4% above the Medical Devices & Instruments industry median of 1.67. Dentsply Sirona's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current 3-Year ROIIC % is 3.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $12.32 is trading 35.3% below its estimated GF Value™ of $19.03.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
3-Year ROIIC %: 3.73 (19% above median its 10-year median of 3.13)
GF Value™: $19.03 vs. price of $12.32 (35.3% below fair value)
Industry Position: 123.4% above the Medical Devices & Instruments median (#367 of 799)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
51GF Score
Get the complete analysis for XRAY
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
